Navigation Links
Major disease-vector mosquito reveals the secrets of its immune system
Date:10/1/2010

by Professor Marc Muskavitch from Boston College, the Broad Institute, and Harvard School of Public Health, examined the responses of each mosquito species to different pathogens including parasites, viruses, bacteria, and worms, to identify genes that play a role in mosquito immune defences."Our pathogenomics study took advantage of the sequencing of the Culex quinquefasciatus genome" says Professor Muskavitch, "to bring together data from experiments profiling responses of mosquito genes to pathogen infections, directed by Professor Lyric Bartholomay, with the results of comparative immunogenomics analyses led by Dr Robert Waterhouse". This study revealed many differences among these three mosquito species, and also that Culex, the most geographically widespread, "has an expanded immune gene repertoire, which may enhance its ability to adapt to diverse habitats with different pathogen challenges", explains Dr Waterhouse.

"These important studies" says Professor Zdobnov, "highlight how genome sequencing can greatly facilitate detailed experimental investigations to uncover the complex biology of these major disease-vector mosquitoes". Professor Bartholomay, from Iowa State University, adds that "by comparing numerous combinations of mosquito species infected with different pathogen types, our results indicate that pathogens that successfully develop in, and are transmitted by, disease-vector mosquitoes, have evolved to avoid mosquito immune responses". Improving our understanding of these vector-pathogen relationships significantly advances the long-term objectives of developing strategies to reinforce the mosquitoes' defences, making them immune to infections and breaking the chain of pathogen transmission.


'/>"/>

Contact: Irene Perovsek
irene.perovsek@isb-sib.ch
41-216-924-050
Swiss Institute of Bioinoformatics
Source:Eurekalert

Page: 1 2

Related biology technology :

1. deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma
2. All-New Sermo Brings Major Enhancements to Nations Largest Online Physician Community
3. deCODE Discovers Genetic Risk Factor Linking Susceptibility to Four Major Vascular Diseases
4. Iowa Gains Momentum as Major Provider of Biorenewables
5. Orexigen(R) Therapeutics Announces That Contrave(R) Reduced Depression Scores and Body Weight in Overweight and Obese Patients With Major Depression
6. University of Minnesota researchers clear major hurdle in road to high-efficiency solar cells
7. Lexicon to Present at Two Major Healthcare Investor Conferences
8. Sensient Technologies Corporation Announces Major Investment in Natural Colors
9. Encorium Group, Inc. Announces New Business Contract Wins of $6.8 Million, Including Two Pivotal Phase III Studies for a Major Asian Technology Company
10. Epeius Biotechnologies Reports Major Clinical Advances: Noteworthy Clinical Case Studies in Cancer Gene Therapy
11. Graphene films clear major fabrication hurdle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Xeno ... Excellence following its most recent COLA inspection. Xeno ... COLA, a national healthcare accreditation organization. Accreditation is ... of quality in day-to-day operations, demonstrate continued accuracy ... a rigorous on-site laboratory survey. , ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic disease, today announced the next step in ... premier bio-analytics solutions provider with the naming of current ... and Chief Executive Officer, while current Chairman of the ... to serve as Chairman. These changes are effective January ...
(Date:12/17/2014)... SAN FRANCISCO, Calif. , Dec. 17, 2014 ... results of a Phase 2 study evaluating the ... the treatment of patients with severe, chronic itch ... current standard of care, including topical steroids and ... was percent change in Visual Analog Scale (VAS) ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel ... (NASDAQ: BCLI ), a leading developer of ... that wholly-owned subsidiary Brainstorm Cell Therapeutics Ltd. was awarded ... Israel,s Office of the Chief Scientist (OCS).  ... in receipt of grant support from the Office of ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
... JERUSALEM, September 9 Oramed Pharmaceticals,Inc. (OTCBB: ... that it has received approval from the Institutional Review ... GLP-1 Analog. This approval was,granted after successful pre-clinical results ... at Hadassah University Medical Center in,Jerusalem. , ...
... 9 , - Tata ... for Health Care , Global ... of its first business vertical-focused learning,solutions for organizations in ... the appointment of Candida Chandorkar as Vice,President - Global ...
... , , , , ... SAN FRANCISCO, Sept. 9 Medivation, Inc. (Nasdaq: MDVN ) ... the following conferences: , , , The ... Eastern Time at the Millennium Broadway Hotel in New York , ...
Cached Biology Technology:Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog 2Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog 3Tata Interactive Systems Initiates Vertical-Focused Learning Solutions for Health Care, Pharmaceutical, and Biotechnology 2Tata Interactive Systems Initiates Vertical-Focused Learning Solutions for Health Care, Pharmaceutical, and Biotechnology 3Tata Interactive Systems Initiates Vertical-Focused Learning Solutions for Health Care, Pharmaceutical, and Biotechnology 4Medivation Announces Participation in Upcoming Conferences 2
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
(Date:12/5/2014)...  Tute Genomics, a leader in cloud-based solutions for ... funding led by UK-based Eurovestech. Peak Ventures and a ... round. "We are at a pivotal time ... and seeks new approaches for the diagnosis, treatment and ... MBA, and CEO of Tute Genomics. "One of the ...
(Date:11/21/2014)... According to a new market ... RFID, Access Control, Intrusion Detection, Parking Management, Under Vehicle ... Service Geography - Global Forecasts to 2020", published by ... be around $25 Billion in 2014 and is expected ... CAGR of 8.69%. Browse 116 market data ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... hyperspectral scanner from the Finnish SPECIM company, the first of ... in depth of applications that require the analysis of images ... as SisuCHEMA, is a work station that integrates all the ... a spectral range of 900 to 2500nm, known as SWIR ...
... Rochelle, NY, May 27, 2009New guidelines designed to standardize ... with Medullary Thyroid Carcinoma (MTC), an uncommon and challenging ... American Thyroid Association and published online ahead of print ... Mary Ann Liebert, Inc. ( www.liebertpub.com ). The guidelines ...
... Pengue and Iliana Monterroso, is the product of collaborative ... Buenos Aires and the Latin American Faculty of Social ... advance of the invasion beyond the Pampas, it reviews ... the major drivers and pressures in the context of ...
Cached Biology News:First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal 2Weed resistance to glyphosate in genetically modified soybean cultivation in Argentina 2
For mRNA Differential Display with three one-base anchored oligo-dT primers and rationally designed arbitrary 13mers. These kits feature the latest generation of isotopic mRNA Differential Display t...
Request Info...
... Panomer 9 oligodeoxynucleotides ... are labeled at the ... proprietary Alexa Fluor dyes ... for assessing microarray spot ...
Topoisomerase I, isolated from wheat germ, is an enzyme capable of removing negative supercoils from covalently closed circular DNA (1)....
Biology Products: